Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-019771
Filing Date
2025-03-04
Accepted
2025-03-04 08:49:56
Documents
79
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0232194-10k_adial.htm   iXBRL 10-K 1747962
2 INSIDER TRADING POLICY ea023219401ex19-1_adial.htm EX-19.1 64797
3 CONSENT OF MARCUM LLP ea023219401ex23-1_adial.htm EX-23.1 2396
4 CERTIFICATION ea023219401ex31-1_adial.htm EX-31.1 7985
5 CERTIFICATION ea023219401ex31-2_adial.htm EX-31.2 8168
6 CERTIFICATION ea023219401ex32-1_adial.htm EX-32.1 3819
7 CERTIFICATION ea023219401ex32-2_adial.htm EX-32.2 3675
  Complete submission text file 0001213900-25-019771.txt   7244086

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE adil-20241231.xsd EX-101.SCH 53599
9 XBRL CALCULATION FILE adil-20241231_cal.xml EX-101.CAL 56929
10 XBRL DEFINITION FILE adil-20241231_def.xml EX-101.DEF 266394
11 XBRL LABEL FILE adil-20241231_lab.xml EX-101.LAB 537432
12 XBRL PRESENTATION FILE adil-20241231_pre.xml EX-101.PRE 292464
81 EXTRACTED XBRL INSTANCE DOCUMENT ea0232194-10k_adial_htm.xml XML 736026
Mailing Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901
Business Address 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901 434-422-9800
ADIAL PHARMACEUTICALS, INC. (Filer) CIK: 0001513525 (see all company filings)

EIN.: 800667150 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38323 | Film No.: 25701720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)